Výsledky vyhledávání - "David Robert Freyer"

Male fertility preservation (FP) at pediatric cancer centers: A report from the Children’s Oncology Group (COG)

Autor: Jennifer Levine, Julienne Brackett, Brooke Cherven, Natasha Frederick, James L. Klosky, Sameeya Ahmed-Winston, Elyse Bryson, Joanne Frankel Kelvin, Gwendolyn P. Quinn, Lillian R. Meacham, David Robert Freyer, Christopher C. Dvorak, Eric Jessen Chow

Publikováno v: Journal of Clinical Oncology. 37:10050-10050

10050 Background: Preserved fertility after cancer is a priority for male survivors and their families. Sperm banking (SB) before initiation of treatment is standard of care for post-pubertal males. Experimental testicular tissue cryopreservation (TT

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::70a8ac8e0eaed921368cfc74db031393
https://doi.org/10.1200/jco.2019.37.15_suppl.10050

Zobrazit plný text záznamu

Comparison of Vincristine Pharmacokinetics (PK) in Adolescent/Young Adult (AYA) Versus Younger Patients Defined By Tanner Stage during Treatment for Acute Lymphoblastic Leukemia (ALL)

Autor: Leidy L Isenalumhe, Ashley S. Margol, Stan Louie, Michael Neely, Richard Sposto, Jemily Malvar, David Robert Freyer

Publikováno v: Blood. 126:3725-3725

Introduction: For many forms of cancers, survival improvement in the AYA population has lagged behind that of younger patients. One contributing factor could be differences in drug metabolism and tolerance of cancer treatment. Although previous studi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e4f026ec0e52d338d8224ad94d7885e4
https://doi.org/10.1182/blood.v126.23.3725.3725

Zobrazit plný text záznamu

Survival after Relapse in Higher Risk Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents Is Independent of Prior Treatment Intensity: A Report from the Children’s Oncology Group (COG)

Autor: Stephen P. Hunger, David Robert Freyer, Paul S. Gaynon, William L. Carroll, Nita L. Seibel, Meenakshi Devidas, Mei K. La

Publikováno v: Blood. 112:917-917

While intensification of therapy has improved event-free survival (EFS) and survival in newly diagnosed patients, outcomes after relapse have proved more difficult. In randomized clinical trials where statistically significant treatment-related diffe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::911ae8187d99ffe5c92f12d0d3a2ec84
https://doi.org/10.1182/blood.v112.11.917.917

Zobrazit plný text záznamu

Outcomes in Children and Adolescents with a Markedly Elevated White Blood Cell Count (>200,000) at Diagnosis of High Risk Acute Lymphoblastic Leukemia (ALL): A Report from the Children’s Oncology Group

Autor: Peter G. Steinherz, Charles M. Rubin, Allan F. Pyesmany, David Robert Freyer, Caroline Hastings, Cheryl Edens, Harland Sather, Janet Franklin, Leonard A. Mattano, James B. Nachman, Nita L. Seibel, Paul S. Gaynon, Torrey L. Mitchell, Lawrence J. Ettinger, Cynthia DeLaat, Kathy Bertolone, Nyla A. Heerema

Publikováno v: Blood. 108:1870-1870

In prior studies, children and adolescents with markedly elevated (ME) WBC≥200,000 had a poor outcome. We examined the outcome of these patients enrolled on CCG l961 (n=250) and compared them to other patients with WBC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::599c96b059c310e9c08443201fe6de75
https://doi.org/10.1182/blood.v108.11.1870.1870

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání